Clinical Trials Arena on MSN57m
Alphamab doses first subject in trial of JSKN003 for ovarian cancer
Alphamab Oncology has dosed the first subject in the randomised Phase III JSKN003-306 trial of its anti-human epidermal ...
SiouxlandProud.com on MSN20m
Many Nebraskans still under threat of high nitrate in drinking water, report finds
Rural Nebraska’s nitrate problem doesn’t appear to be getting any better – the results of the recent testing are roughly in line with the 20-year testing average for private wells.